fesoterodine medical valley forðatafla 8 mg
medical valley invest ab - fesoterodinum fúmarat - forðatafla - 8 mg
fesoterodine medical valley forðatafla 4 mg
medical valley invest ab - fesoterodinum fúmarat - forðatafla - 4 mg
folsyra evolan tafla 5 mg
evolan pharma ab - folic acid - tafla - 5 mg
pemetrexed w&h stofn fyrir innrennslisþykkni, lausn 500 mg
williams & halls ehf. - pemetrexedum dínatríum - stofn fyrir innrennslisþykkni, lausn - 500 mg
pemetrexed wh (pemetrexed synthon) innrennslisþykkni, lausn 25 mg/ml
williams & halls ehf. - pemetrexedum inn - innrennslisþykkni, lausn - 25 mg/ml
lorviqua
pfizer europe ma eeig - lorlatinib - krabbamein, lungnakrabbamein - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
stilnoct filmuhúðuð tafla 10 mg
sanofi-aventis norge as - zolpidemum tartrat - filmuhúðuð tafla - 10 mg
caverject dual stungulyfsstofn og leysir, lausn 10 míkróg
pfizer aps - alprostadilum inn - stungulyfsstofn og leysir, lausn - 10 míkróg
caverject dual stungulyfsstofn og leysir, lausn 20 míkróg
pfizer aps - alprostadilum inn - stungulyfsstofn og leysir, lausn - 20 míkróg
librax húðuð tafla
viatris aps - clidinii bromidum inn; chlordiazepoxidum inn - húðuð tafla